US 8273724
Melanoma antigens and their use in diagnostic and therapeutic methods
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 8273724 (Melanoma antigens and their use in diagnostic and therapeutic methods) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K2239/57, A61K38/00